CADTH | Search

Current Filters

Showing 71 - 80 results of 3579

Bosulif for Chronic Myeloid Leukemia - Details (Bosulif) (Last Updated: Jun 4, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Bosulif
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Initial

Avastin for Ovarian Cancer - Details (Avastin) (Last Updated: Jun 26, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Avastin
Manufacturer:
Hoffmann-La Roche Limited
Submission Type:
Initial

Arzerra for Chronic Lymphocytic Leukemia - Details (Arzerra) (Last Updated: Feb 23, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Arzerra
Manufacturer:
GlaxoSmithKline Inc.
Submission Type:
Initial

Afinitor for Advanced Breast - Details (Afinitor) (Last Updated: Apr 11, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Afinitor
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Initial

Afinitor for pancreatic neuroendocrine tumours - Details (Afinitor) (Last Updated: Sep 18, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Afinitor
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Initial

Adcetris for Hodgkin Lymphoma - Details (Adcetris) (Last Updated: Sep 17, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Adcetris
Manufacturer:
Seattle Genetics, Inc.
Submission Type:
Initial

Ulipristal acetate (Fibristal) (Last Updated: Apr 17, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Fibristal
Manufacturer:
Actavis Specialty Pharmaceuticals Co.
Submission Type:
Initial
Indications:

Uterine fibroids (signs and symptoms)

Download results as CSV